340B Benefit Update

Eli Lilly 340B Requirement

Now that Eli Lilly has moved to claims-level 340B submissions, QuicksortRx gives you the tools to quantify risks and respond quickly to protect your 340B savings. 

Request your personalized analysis.

Act Now To Protect Millions In Savings

On January 15, Eli Lilly announced that all covered entities must submit claims-level data to maintain their 340B pricing effective February 1. Health systems now have only a brief window to ensure compliance and avoid severe financial losses. 

Why It Matters:

  • Inaction = Lose Eli Lilly 340B Pricing: Lose access to 340B pricing for Eli Lilly products if claims-level data isn't submitted on time.
  • Tight reporting window: Claims must be made within 30-45 days of purchase.
  • Operational Hurdles: Urgency to finalize the infrastructure and legal clearances to share claims data securely.

 

How QuicksortRx Helps:

  • Instantly report 340B savings by supplier to assess the impact
  • Quickly respond to internal financial or legal questions with validated data
  • Educate internal stakeholders on new Eli Lilly policy implications 

340B Benefit Tool Update

Rapidly project potential 340B savings losses by supplier based on your current purchasing patterns, giving your teams the concrete data they need to prioritize immediate action.

340B Rebate Pilot Report (NEW)

Pinpoint your hospital’s exposure under the proposed IRA NDC rebate pilot.

Know exactly how much cash you may need to float while waiting for rebate returns on the 400 IRA NDCs. Get ongoing insights into IRA medication spend, WAC changes, and rebate forecasts.

340B Rebate Pilot Report (NEW)

Pinpoint your hospital’s exposure under the new rebate model.

Know exactly how much cash you may need to float while waiting for rebate returns on the 400 IRA NDCs. Get ongoing insights into IRA medication spend, WAC changes, and rebate forecasts.

340B Rebate Pilot Report (NEW)

Pinpoint your hospital’s exposure under the proposed 340B Rebate Pilot.

Know exactly how much cash you may need to float while waiting for rebate returns on the 400 IRA NDCs. Get ongoing insights into IRA medication spend, WAC changes, and rebate forecasts.

What's Next?

Build For What's Coming

QuicksortRx is constantly evolving to help you stay ahead of the latest 340B policy and regulatory changes. Our team is here to guide you through today's challenges while developing new tools that power your future workflows.